Net Cash Provided by (Used in) Financing Activities of Bausch Health Companies Inc. from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Bausch Health Companies Inc. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • Bausch Health Companies Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $146,000,000, a 57% increase year-over-year.
  • Bausch Health Companies Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $742,000,000, a 15% increase from 2024.
  • Bausch Health Companies Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $868,000,000, a 159% decline from 2023.
  • Bausch Health Companies Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1,475,000,000.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

Bausch Health Companies Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $742,000,000 +$126,000,000 +15% 01 Jan 2025 31 Dec 2025 10-K 19 Feb 2026 2025 FY
2024 $868,000,000 -$2,343,000,000 -159% 01 Jan 2024 31 Dec 2024 10-K 19 Feb 2026 2025 FY
2023 $1,475,000,000 +$1,949,000,000 01 Jan 2023 31 Dec 2023 10-K 19 Feb 2026 2025 FY
2022 $474,000,000 +$1,039,000,000 +69% 01 Jan 2022 31 Dec 2022 10-K 20 Feb 2025 2024 FY
2021 $1,513,000,000 +$781,000,000 +34% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 $2,294,000,000 -$3,737,000,000 -259% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
2019 $1,443,000,000 +$2,796,000,000 01 Jan 2019 31 Dec 2019 8-K 11 May 2022
2018 $1,353,000,000 +$3,610,000,000 +73% 01 Jan 2018 31 Dec 2018 8-K 04 May 2021 2020 FY
2017 $4,963,000,000 -$3,000,000,000 -153% 01 Jan 2017 31 Dec 2017 10-K 19 Feb 2020 2019 FY
2016 $1,963,000,000 -$15,587,000,000 -114% 01 Jan 2016 31 Dec 2016 10-K 20 Feb 2019 2018 FY
2015 $13,624,000,000 +$16,084,000,000 01 Jan 2015 31 Dec 2015 8-K 10 Aug 2018
2014 $2,460,000,000 -$6,487,700,000 -161% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
2013 $4,027,700,000 +$970,400,000 +32% 01 Jan 2013 31 Dec 2013 10-K 29 Apr 2016 2015 FY
2012 $3,057,300,000 01 Jan 2012 31 Dec 2012 10-K 25 Feb 2015 2014 FY
2010 $213,283,000 01 Jan 2010 31 Dec 2010 10-K 28 Feb 2011 2010 FY

Bausch Health Companies Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $146,000,000 +$194,000,000 +57% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q1 2024 $340,000,000 -$198,000,000 -139% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q1 2023 $142,000,000 -$610,000,000 -130% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q1 2022 $468,000,000 +$711,000,000 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $243,000,000 +$1,278,000,000 +84% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $1,521,000,000 -$1,371,000,000 -914% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q1 2019 $150,000,000 +$138,000,000 +48% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $288,000,000 +$1,154,000,000 +80% 01 Jan 2018 31 Mar 2018 10-Q 06 May 2019 2019 Q1
Q1 2017 $1,442,000,000 -$1,702,000,000 -655% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q1 2016 $1,577,700,000 $260,000,000 -$12,046,300,000 -98% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q4 2015 $13,624,000,000 $100,900,000 +$1,199,500,000 01 Oct 2015 31 Dec 2015 8-K 10 Aug 2018
Q3 2015 $12,424,500,000 $108,500,000 +$973,600,000 +90% 01 Jul 2015 30 Sep 2015 10-Q 26 Oct 2015 2015 Q3
Q2 2015 $11,450,900,000 $1,325,300,000 +$1,481,900,000 01 Apr 2015 30 Jun 2015 10-Q 28 Jul 2015 2015 Q2
Q1 2015 $9,969,000,000 $12,306,300,000 +$12,429,000,000 01 Jan 2015 31 Mar 2015 10-Q 07 Jun 2016 2016 Q1
Q4 2014 $2,460,000,000 $1,098,600,000 01 Oct 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
Q3 2014 $1,082,100,000 01 Jul 2014 30 Sep 2014 10-Q 26 Oct 2015 2015 Q3
Q2 2014 $156,600,000 01 Apr 2014 30 Jun 2014 10-Q 28 Jul 2015 2015 Q2
Q1 2014 $122,700,000 01 Jan 2014 31 Mar 2014 10-Q 30 Apr 2015 2015 Q1
Q2 2011 $237,519,000 $330,169,000 -$304,667,000 -1195% 01 Apr 2011 30 Jun 2011 10-Q 08 Aug 2011 2011 Q2
Q1 2011 $542,186,000 $742,767,000 +$755,469,000 01 Jan 2011 31 Mar 2011 10-Q 10 May 2011 2011 Q1
Q4 2010 $213,283,000 $164,489,000 01 Oct 2010 31 Dec 2010 10-K 28 Feb 2011 2010 FY
Q3 2010 $10,590,000 01 Jul 2010 30 Sep 2010 10-Q 05 Nov 2010 2010 Q3
Q2 2010 $25,502,000 01 Apr 2010 30 Jun 2010 10-Q 08 Aug 2011 2011 Q2
Q1 2010 $12,702,000 01 Jan 2010 31 Mar 2010 10-Q 10 May 2011 2011 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.